KCC009 is a competitive transglutaminase 2 (TG2) inhibitor (IC50 = 20 µM). It sensitizes cancer cells to chemotherapy by blocking TG2-mediated survival signaling in glioblastoma research.
Molecular Weight:
476.32
Purity:
98.68%
CAS Number:
[744198-19-4]
Formula:
C21H22BrN3O5
Target:
Glutaminase
T27717
T27717
* VAT and and shipping costs not included. Errors and price changes excepted